Lowering cholesterol has long been synonymous with statins, but what if you’re among those who can’t tolerate them—or simply want alternatives with fewer side effects?
In a recent discussion, longevity researcher Dr. Rhonda Patrick explored several promising alternatives to statins for managing cardiovascular risk, particularly for those with genetic predispositions like APOE4.
She broke down three compelling options: PCSK9 inhibitors, bempedoic acid, and ezetimibe—each with distinct mechanisms and benefits.
Here’s what makes each one worth discussing with your healthcare provider.
Jump to:
PCSK9 Inhibitors: Powerful But Pricey
PCSK9 inhibitors represent one of modern medicine’s most effective lipid-lowering therapies. They work by preventing degradation of LDL receptors in your liver, essentially increasing the number of receptors available to clear apoB particles from circulation.
It’s mechanism of action removes APOB particles in plasma via LDL receptors, which the liver internalizes upon binding to the LDL particle.
Dr. Patrick noted that these drugs are highly effective with virtually no side effects beyond occasional injection site reactions. Clinical trials with follow-up periods extending to 26 months have shown remarkable safety profiles.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
But there’s a significant catch: cost. At approximately $500 monthly, insurance companies typically only cover PCSK9 inhibitors when patients experience adverse reactions to statins. This financial barrier puts them out of reach for many who could benefit.
Bempedoic Acid: Liver-Specific Action
What Peter Attia calls a “pro drug,” bempedoic acid offers something statins cannot: targeted action exclusively in liver cells.
How It Works Differently
After ingestion, bempedoic acid remains inactive until metabolized by your liver. Once activated, it inhibits cholesterol synthesis only in hepatocytes—not throughout your entire body like statins do.
It’s a very targeted effect, and that really distinguishes it from statins with respect to it only affecting the liver.
This mechanism triggers your liver to increase LDL receptors on its surface, capturing more LDL from blood and lowering cholesterol levels. Because it doesn’t affect mitochondria in muscle and other tissues, bempedoic acid avoids many statin-related side effects.
Safety Profile and Considerations
Long-term studies extending to 130 weeks show bempedoic acid is well-tolerated. Most frequent adverse effects include muscle spasms, though these primarily occur in patients taking other medications concurrently.
The most important consideration? Uric acid elevation.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
Dr. Patrick emphasized monitoring uric acid levels, particularly for individuals predisposed to gout. Elevated uric acid can trigger gout attacks, making regular testing essential for anyone using bempedoic acid.
That is something to keep in mind particularly in people that are already predisposed to gout, and obviously monitoring uric acid levels is important for anyone that is going to be using bempedoic acid.
While bempedoic acid doesn’t lower apoB as dramatically as statins, it provides meaningful reduction for those seeking modest lipid improvements without harsh side effects.
Ezetimibe: The Absorption Blocker
Ezetimibe takes an entirely different approach—blocking cholesterol absorption rather than synthesis.
Dual-Action Mechanism
Working in your small intestine, ezetimibe inhibits a protein called NPC1L1 that’s crucial for cholesterol absorption. This blocks uptake of both dietary cholesterol and cholesterol produced by your liver.
It also affects absorption of plant sterols, compounds structurally similar to cholesterol. By preventing cholesterol from entering enterocytes (intestinal cells), ezetimibe reduces the amount delivered to your liver and decreases overall liver cholesterol stores.
Beyond Lipid Lowering
Ezetimibe offers additional health benefits that extend beyond cholesterol management:
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
- Reduced inflammatory biomarkers
- Improved insulin resistance (unlike statins, which worsen it)
- Benefits for fatty liver disease
This is in contrast to statins which increase insulin resistance. So it seems like ezetimibe is pretty safe, well tolerated drug.
Clinical efficacy data shows ezetimibe reduces cholesterol by approximately 54%. While less potent than statins, its excellent safety profile makes it attractive for those seeking moderate apoB reduction.
Physicians often prescribe ezetimibe alongside other therapies, though it functions effectively as monotherapy for patients needing modest lipid improvements.
What About Long-Term Data?
Dr. Patrick addressed important questions about long-term safety and mortality outcomes. For PCSK9 inhibitors and newer agents like bempedoic acid, comprehensive all-cause mortality data remains limited.
However, given their mechanisms for lowering apoB particles—a primary driver of atherosclerosis—researchers expect these therapies will demonstrate beneficial effects on cardiovascular mortality, which significantly contributes to all-cause mortality.
Regarding HbA1c concerns with bempedoic acid, Dr. Patrick noted she hasn’t observed increases in this glucose marker. Uric acid elevation remains the primary monitoring consideration.
Ezetimibe appears to improve glucose regulation, offering metabolic advantages beyond lipid management.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
Finding Your Best Option
These alternatives provide genuine options for individuals who cannot tolerate statins or seek therapies with fewer systemic effects. Each drug offers distinct advantages:
- PCSK9 inhibitors: Maximum efficacy with minimal side effects, but expensive
- Bempedoic acid: Liver-specific action avoiding muscle-related issues, watch uric acid
- Ezetimibe: Absorption blocker with metabolic benefits and excellent safety profile
For those with genetic risk factors like APOE4 or concerns about statin-related cognitive effects, these therapies warrant serious discussion with healthcare providers.
None represents a perfect solution for everyone, but each offers targeted mechanisms that may align better with individual health profiles and tolerance thresholds than traditional statin therapy alone.
